Boston Trust Walden Corp Buys 33,693 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Boston Trust Walden Corp grew its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 24.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 174,282 shares of the medical research company’s stock after purchasing an additional 33,693 shares […]